• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Mural Oncology plc - Ordinary Shares (NQ: MURA )

    3.340 -0.060 (-1.76%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 5, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Mural Oncology plc - Ordinary Shares

    < Previous 1 2 Next >
    Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Mural Oncology, Inc.
    Via GlobeNewswire
    Mural Oncology to Present Clinical and Preclinical Data at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
    From Mural Oncology, Inc.
    Via GlobeNewswire
    This MINISO Group Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
    Via Benzinga
    MURA Stock Earnings: Mural Oncology Reported Results for Q1 2024
    Mural Oncology just reported results for the first quarter of 2024. 
    Via InvestorPlace
    MURA Stock Earnings: Mural Oncology Reported Results for Q4 2023
    Mural Oncology just reported results for the fourth quarter of 2023. 
    Via InvestorPlace
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Mural Oncology, Inc.
    Via GlobeNewswire
    Mural Oncology’s First Virtual Investor Day to Highlight Late-Stage Clinical Progress
    From Mural Oncology, Inc.
    Via GlobeNewswire
    Mural Oncology Strengthens Board of Directors with the Appointment of Sachiyo Minegishi
    From Mural Oncology, Inc.
    Via GlobeNewswire
    Mural Oncology to Host First Virtual Investor Day on September 26, 2024
    From Mural Oncology, Inc.
    Via GlobeNewswire
    Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Mural Oncology, Inc.
    Via GlobeNewswire
    Mural Oncology to Present at Two Upcoming Investor Conferences
    From Mural Oncology, Inc.
    Via GlobeNewswire
    Why Workday Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    MURA Stock Earnings: Mural Oncology Beats EPS for Q2 2024
    MURA stock results show that Mural Oncology beat analyst estimates for earnings per share the second quarter of 2024. 
    Via InvestorPlace
    Mural Oncology Announces Second Quarter 2024 Financial Results and Provides Update on Pipeline Progress
    From Mural Oncology, Inc.
    Via GlobeNewswire
    Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Mural Oncology, Inc.
    Via GlobeNewswire
    Mural Oncology Appoints Veteran Business Development Executive George Golumbeski, Ph.D., to its Board of Directors
    From Mural Oncology, Inc.
    Via GlobeNewswire
    Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Mural Oncology, Inc.
    Via GlobeNewswire
    Mural to Present and Host 1x1 Investor Meetings at the 14th Annual East Coast IDEAS Investor Conference
    From Mural Oncology, Inc.
    Via GlobeNewswire
    Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Mural Oncology, Inc.
    Via GlobeNewswire
    Mural Oncology Presents Clinical Data from ARTISTRY-3 at the American Society of Clinical Oncology Annual Meeting
    From Mural Oncology, Inc.
    Via GlobeNewswire
    Mural Oncology Announces First Quarter 2024 Financial Results and Provides Business Update
    From Mural Oncology, Inc.
    Via GlobeNewswire
    Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Mural Oncology, Inc.
    Via GlobeNewswire
    Mural Oncology Announces Upcoming Presentation at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
    From Mural Oncology, Inc.
    Via GlobeNewswire
    Mural Oncology Presents Preclinical Data for IL-18 and IL-12 Programs at the 2024 American Association for Cancer Research Annual Meeting
    From Mural Oncology, Inc.
    Via GlobeNewswire
    Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Mural Oncology, Inc.
    Via GlobeNewswire
    Mural Oncology Announces Fourth Quarter and Year End 2023 Financial Results and Provides Business Update
    From Mural Oncology, Inc.
    Via GlobeNewswire
    Mural Oncology Announces Upcoming Presentations at 2024 American Association for Cancer Research (AACR) Annual Meeting
    From Mural Oncology, Inc.
    Via GlobeNewswire
    Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Mural Oncology, Inc.
    Via GlobeNewswire
    Mural Oncology to Present at the TD Cowen 44th Annual Health Care Conference
    From Mural Oncology, Inc.
    Via GlobeNewswire
    < Previous 1 2 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.